Showing results (351-360 of 1,345) with videos related to
Sort By:
Pageof 135
Vascular Medicine (London, England)|April 7, 2021
Clinical practice patterns and ascertainment bias for cardiovascular events in a randomized trial: A survey of investigators in the BEST-CLI trialMazen S Albaghdadi, Michael N Young, Mohammed M Chowdhury, et al.Vascular Medicine (London, England)|July 2, 2015
Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunctionSophie Blaise, Helena Polena, Isabelle VilgrainVascular Medicine (London, England)|January 19, 2018
Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI testNathan K Itoga, Hataka R Minami, Meenadachi Chelvakumar, et al.Vascular Medicine (London, England)|January 12, 2018
Factor V Leiden paradox in a middle-aged Swedish population: A prospective studyBengt Zöller, Olle Melander, Peter J Svensson, et al.Vascular Medicine (London, England)|March 10, 2018
Short- and long-term mortality after pulmonary embolism in patients with and without cancerGhazi Alotaibi, Cynthia Wu, Ambikaipakan Senthilselvan, et al.Vascular Medicine (London, England)|February 20, 2018
Therapeutic efficacy of CD34+ cell-involved mononuclear cell therapy for no-option critical limb ischemia: A meta-analysis of randomized controlled clinical trialsTianyue Pan, Zheng Wei, Yuan Fang, et al.Vascular Medicine (London, England)|October 6, 2017
The association of race with quality of health in peripheral artery disease following peripheral vascular intervention: The Q-PAD StudyAnwar Zaitoun, Saif Al-Najafi, Thaer Musa, et al.Vascular Medicine (London, England)|March 30, 2007
Use of digital pressure measurements for the diagnosis of AV access-induced hand ischemiaAndres Schanzer, Louis L Nguyen, Christopher D Owens, et al.Vascular Medicine (London, England)|March 30, 2007
The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunctionAlan J Bank, Aaron S Kelly, Daniel R Kaiser, et al.Vascular Medicine (London, England)|August 5, 2006
Sarpogrelate, a 5-hT2A receptor antagonist in intermittent claudication. A phase II European studyL Norgren, A Jawien, L Mátyás, et al.Pageof 135